Since April 2020 the U.S. Food and Drug Administration demanded that producers remove all prescription and over-the-counter ranitidine medications from the market. This act follows the investigation of a ranitidine-related contaminant known as N-Nitrosodimethylamine (NDMA), brand name Zantac.
The FDA found out that, over time, the impurity of the medication increases, potentially exposing its users to prohibited levels of NDMA contaminants.
The older the Zantac or the longer since it has been manufactured, the greater the concentration of NDMA. The same happens when Zantac is stored at temperatures above room temperatures: the higher the storage temperature, the greater the NDMA levels.
NDMA is probably a human carcinogen. At low levels of exposure, NDMA is not likely to cause any harm, as it is commonly found in food and water. However, at higher concentration levels and following prolonged use, there is a high concern associated with NDMA.
The case of raising levels of the contaminant after Zantac storage is therefore very concerning and prompted the FDA to immediately remove the medication from the market.
If you have been taking prescription Zantac, you should ask your doctor for safe replacements for the drug.
If you have been using Zantac for a prolonged period, you may have been exposed to prohibited quantities of NDMA and you may be entitled to receive financial compensation for that. Get in contact with us and our lawyers will be happy to assist you during the whole case!
